DOI QR코드

DOI QR Code

A Retrospective Study of Facial Paralysis Sequelae for Korean Medical Treatment

말초성 안면마비 후유증에 대한 한방 치료를 위한 후향적 차트리뷰 연구

  • Bae, Hyo-Bin (Dept. of Korean Medicine Ophthalmology & Otolaryngology & Dermatology, Clinical Korean Medicine, Dong-Eui University) ;
  • Yoon, Hwa-Jung (Dept. of Korean Medicine Ophthalmology & Otolaryngology & Dermatology, Clinical Korean Medicine, Dong-Eui University) ;
  • Ko, Woo-Shin (Dept. of Korean Medicine Ophthalmology & Otolaryngology & Dermatology, Clinical Korean Medicine, Dong-Eui University)
  • 배효빈 (동의대학교 부속한방병원 한방안이비인후피부과) ;
  • 윤화정 (동의대학교 부속한방병원 한방안이비인후피부과) ;
  • 고우신 (동의대학교 부속한방병원 한방안이비인후피부과)
  • Received : 2019.01.12
  • Accepted : 2019.02.05
  • Published : 2019.02.25

Abstract

Objectives : The purpose of this study is to confirm and to suggest the Korean medical treatment is effective treatments to patients with facial paralysis sequelae. Methods : We conducted a survey on patients with facial paralysis sequelae who visited the facial paralysis center from August 2017 to November 2018. We then evaluated House-Brackmann Grading System(HBGS), Sunnybrook Scale(S-Scale), Visual analog scale(VAS) against those who agreed and analyzed the information through Electronic Medical Record(EMR) and Order Communication System(OCS). Results : Clinically, Korean medical treatment such as embedding therapy are effective for the facial paralysis sequelae. For the purpose of raising the level of evidence against this, research will be needed to confirm the treatment effects by comparing accurate assessment indicators that are conducted before and after the treatment. Conclusions : In order to confirm the progress of treatment of facial paralysis sequelae, evaluation indicators such as House-Brackmann Grading System and Sunnybrook Scale should be performed by experts. And after 3-4 weeks, if patients have any sequelae symptoms, it may be helpful to take treatments such as pharmacopuncture treatment and embedding therapy at intervals of 1-2 weeks depending on the symptoms or areas.

Keywords

OOBHC1_2019_v32n1_59_f0001.png 이미지

Fig. 1. Flow Chart

OOBHC1_2019_v32n1_59_f0002.png 이미지

Fig. 2. Scatter Plot

OOBHC1_2019_v32n1_59_f0003.png 이미지

Fig. 3. Scatter Plot

OOBHC1_2019_v32n1_59_f0004.png 이미지

Fig. 4. Scatter Plot

OOBHC1_2019_v32n1_59_f0005.png 이미지

Fig. 5. Scatter Plot

OOBHC1_2019_v32n1_59_f0006.png 이미지

Fig. 6. Scatter Plot

OOBHC1_2019_v32n1_59_f0007.png 이미지

Fig. 7. Scatter Plot

Table 1. Sex Distribution

OOBHC1_2019_v32n1_59_t0001.png 이미지

Table 2. Age Distribution

OOBHC1_2019_v32n1_59_t0002.png 이미지

Table 3. Affected Side

OOBHC1_2019_v32n1_59_t0003.png 이미지

Table 4. Treatment Start Time

OOBHC1_2019_v32n1_59_t0004.png 이미지

Table 5. Nerve Conduction Study (%)

OOBHC1_2019_v32n1_59_t0005.png 이미지

Table 6. House-Brackmann Grading System (HBGS)

OOBHC1_2019_v32n1_59_t0006.png 이미지

Table 7. Change of House-Brackmann Grading System

OOBHC1_2019_v32n1_59_t0007.png 이미지

Table 8. Sunnybrook Scale (S-Scale)

OOBHC1_2019_v32n1_59_t0008.png 이미지

Table 9. Visual Analog Scale (VAS)

OOBHC1_2019_v32n1_59_t0009.png 이미지

Table 10. Sequelae Symptom

OOBHC1_2019_v32n1_59_t0010.png 이미지

Table 11. Number of Embedding Therapy Treatment

OOBHC1_2019_v32n1_59_t0011.png 이미지

Table 12. Descriptive Statistics

OOBHC1_2019_v32n1_59_t0012.png 이미지

Table 13. Correlations

OOBHC1_2019_v32n1_59_t0013.png 이미지

Table 14. Descriptive Statistics

OOBHC1_2019_v32n1_59_t0014.png 이미지

Table 15. Correlations

OOBHC1_2019_v32n1_59_t0015.png 이미지

Table 16. Descriptive Statistics

OOBHC1_2019_v32n1_59_t0016.png 이미지

Table 17. Correlations

OOBHC1_2019_v32n1_59_t0017.png 이미지

Table 18. Descriptive Statistics

OOBHC1_2019_v32n1_59_t0018.png 이미지

Table 19. Correlations

OOBHC1_2019_v32n1_59_t0019.png 이미지

Table 20. Descriptive Statistics

OOBHC1_2019_v32n1_59_t0020.png 이미지

Table 21. Correlations

OOBHC1_2019_v32n1_59_t0021.png 이미지

Table 22. Descriptive Statistics

OOBHC1_2019_v32n1_59_t0022.png 이미지

Table 23. Correlations

OOBHC1_2019_v32n1_59_t0023.png 이미지

References

  1. Jose F, Raquel R, Isabel G, Pedro V, Nuno B, Artur C. Peripheral Facial Palsy in Emergency Department. Iran J Otorhinolaryngol. 2018;30(98):145-52.
  2. Somasundara D, Sullivan F. Management of Bell's palsy. Aust Prescr. 2017;40(3):94-7. https://doi.org/10.18773/austprescr.2017.030
  3. Ryu SH, Lee SY, Kim HG, Ryoo DW, Kim SJ, Jeong SM, et al. Preliminary Study to Develop an Objective Method for Evaluating Facial Palsy Sequelae Using Facial Scanning System. The Acupuncture. 2016;33(3):89-99. https://doi.org/10.13045/acupunct.2016037
  4. Rhee DH, Choi JH, Park SY, Kim JH. Clinical Study of Three Cases of Recurrent Peripheral Facial Nerve Palsy with Sequelae. J Korean Med Ophthalmol Otolaryngol Dermatol. 2012;25(4):57-69. https://doi.org/10.6114/jkood.2012.25.4.057
  5. Lee JW, Kwon SA, Kim MJ, Song JY, Kim PK, Seo BK, et al. A Study of Facial Palsy Sequelae and Evaluating Scale. The Acupuncture. 2011;28(2):75-87.
  6. Ji YS, Lee SM, Lee CW, Jeon JH, Kim YI. Survey on Satisfaction of Needle-Nembedding Therapy on Sequelae of Peripheral Facial Palsy. Journal of the Spine&Joint Korean Medicine. 2012;9(1):41-9.
  7. Cho E, Kang JH, Lee H. Case Study of Jung-an Acupuncture on the Sequelae of Peripheral Facial Palsy. The Acupuncture. 2013;30(3):155-63. https://doi.org/10.13045/acupunct.2013015
  8. Lee SE, Yoon HJ, Ko WS. Research Trends on Non-surgical Treatment of Peripheral Facial Paralysis Sequelae. J Korean Med Ophthalmol Otolaryngol Dermatol. 2018;31(4):42-64. https://doi.org/10.6114/JKOOD.2018.31.1.042
  9. Korea Institute of Oriental Medicine. Idiopathic Facial Palsy Korean Medicine Clinical Practice Guideline. 1st ed. Seoul:Elsevier Korea LLC. 2015.
  10. Korean Society of Otorhinolaryngology-Head and Neck Surgery. Otorhinolaryngology. 1st ed. Seoul:Ilchokak. 2016:208-15.
  11. Nicholas B, Melanie G, Amrita R, Michael J. Update in Facial Nerve Paralysis: Tissue engineering and new technologies. Curr Opin Otolaryngol Head Neck Surg. 2014;22(4):291-9. https://doi.org/10.1097/MOO.0000000000000062
  12. Ritvik P. Surgical Treatment of Facial Paralysis. Clinical and Experimental Otorhinolaryngology. 2009;2(1);1-5. https://doi.org/10.3342/ceo.2009.2.1.1
  13. Won JS, Chou CY, Cho AR, Kim CH. The Clinical Observation of Bell's palsy sequela. J Korean Med Ophthalmol Otolaryngol Dermatol. 2009;22(3):167-77.
  14. Hong KE. Comprehension of Embedding Therapy Through Meridian Muscle System -Focused on Face-. The Acupuncture. 2008;25(3):215-9.
  15. Kim DH, Kim JH. Hwangjenaekyeong Yeongchu. 1st ed. Seoul:Uiseongdang. 2002.
  16. Lee EM, Park DS, Kim DH, Kim HW, Jo EH, Ahn MS, et al. A Literature Study and Recent Tendency on Oriental Correction of Deformities and "Needle-embedding Therapy". The Acupuncture. 2008;25(3): 229-36.
  17. Kim MB, Kim JH, Shin SH, Yoon HJ, Ko WS. A study of facial nerve grading system. J Korean Med Ophthalmol Otolaryngol Dermatol. 2007;20(3):147-60.
  18. Korean Pharmacopuncture Institute. Pharmacopuncturology. 2nd ed. Seoul:Elsevier Korea LLC. 2011:208-22.
  19. Choi CH, Song HS. Effect of Bee Venom Phamacopuncture Complex Therapy on Residual Symptom of Bell's Palsy After the Early Stage. The Acupuncture. 2009;26(4): 115-23.
  20. Kim JH, Jeong JY, Lee SW, Shin SY, Park JH, Kim CH, et al. Comparison of the Efficacy between Needle-embedding Therapy ans Sweet Bee Venom Pharmacopuncture Therapy on Peripheral Facial Paralysis. The Acupuncture. 2013;30(4):35-44. https://doi.org/10.13045/acupunct.2013020